Paper20437116
Oral cancer chemotherapy: the critical interplay between patient education and patient safety.
Halfdanarson TR and 1 other. Curr Oncol Rep, 2010. Cited by 68 papers, by iCite.
Cite this record
ConductScience Library. Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Papers, record 20437116. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20437116
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Oral cancer chemotherapy: the critical interplay between patient education and patient safety.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Neoplasms | Major topic |
| Administration, Oral | |
| Humans | |
| Patient Compliance | |
| Patient Education as Topic | |
| Self Administration |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K24 CA131099 | NCI NIH HHS | United States | K24CA131099 | PubMed and NIH | NIH RePORTER |
| R21 CA134432 | NCI NIH HHS | United States | R21CA134432 | PubMed | NIH RePORTER |
| K24CA131099 | NCI NIH HHS | United States | K24CA131099 | PubMed and NIH | NIH RePORTER |
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19692680 | Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19692680 | PubMed |
| 2 | 15987918 | Capecitabine as adjuvant treatment for stage III colon cancer. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15987918 | PubMed |
| 3 | 18063536 | Oral chemotherapy medications: the need for a nurse's touch. | Clin J Oncol Nurs | 2007 | https://conductscience.org/library/papers/18063536 | PubMed |
| 4 | 11709569 | Activity of oral fludarabine phosphate in previously treated chronic lymphocytic leukemia. | J Clin Oncol | 2001 | https://conductscience.org/library/papers/11709569 | PubMed |
| 5 | 16512995 | A retrospective study of coagulation abnormalities in patients receiving concomitant capecitabine and warfarin. | Clin Colorectal Cancer | 2006 | https://conductscience.org/library/papers/16512995 | PubMed |
| 6 | 8996131 | Patient preferences for oral versus intravenous palliative chemotherapy. | J Clin Oncol | 1997 | https://conductscience.org/library/papers/8996131 | PubMed |
| 7 | 19306355 | First-line therapy for chronic myeloid leukemia: Past, present, and future. | Am J Hematol | 2009 | https://conductscience.org/library/papers/19306355 | PubMed |
| 8 | 19188677 | Effects of food on the relative bioavailability of lapatinib in cancer patients. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19188677 | PubMed |
| 9 | 19150950 | Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer. | Ann Oncol | 2009 | https://conductscience.org/library/papers/19150950 | PubMed |
| 10 | 17223629 | Oral chemotherapy safety practices at US cancer centres: questionnaire survey. | BMJ | 2007 | https://conductscience.org/library/papers/17223629 | PubMed |
| 11 | 17513814 | Phase III study of oral compared with intravenous topotecan as second-line therapy in small-cell lung cancer. | J Clin Oncol | 2007 | https://conductscience.org/library/papers/17513814 | PubMed |
| 12 | 9563888 | Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients. | Clin Cancer Res | 1998 | https://conductscience.org/library/papers/9563888 | PubMed |
| 13 | 18985046 | Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. | Br J Cancer | 2008 | https://conductscience.org/library/papers/18985046 | PubMed |
| 14 | 17925496 | Sensitivity of patient outcomes to pharmacist interventions. Part II: Systematic review and meta-analysis in hypertension management. | Ann Pharmacother | 2007 | https://conductscience.org/library/papers/17925496 | PubMed |
| 15 | 8270984 | Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer. | J Clin Oncol | 1994 | https://conductscience.org/library/papers/8270984 | PubMed |
| 16 | 16198223 | Adherence beliefs among breast cancer patients taking tamoxifen. | Patient Educ Couns | 2005 | https://conductscience.org/library/papers/16198223 | PubMed |
| 17 | 16155797 | Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer. | Breast Cancer Res Treat | 2005 | https://conductscience.org/library/papers/16155797 | PubMed |
| 18 | 19786650 | American Society Of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19786650 | PubMed |
| 19 | 19816160 | A pilot study of an automated voice response system and nursing intervention to monitor adherence to oral chemotherapy agents. | Cancer Nurs | 2009 | https://conductscience.org/library/papers/19816160 | PubMed |
| 20 | 18377852 | NCCN Task Force Report: Oral chemotherapy. | J Natl Compr Canc Netw | 2008 | https://conductscience.org/library/papers/18377852 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42732435 | The Effect of Two Different Pharmacist-led Educations Provided to Patients with Colorectal Cancer Receiving an Oral Antineoplastic Agent: A Comparative Interventional Study. | J Res Pharm Pract | 2026 | https://conductscience.org/library/papers/42732435 | PubMed |
| 41707192 | A Short Patient-Reported Outcome Measure for Oral Anticancer Agents: Multicenter Observational Study. | JMIR Form Res | 2026 | https://conductscience.org/library/papers/41707192 | PubMed |
| 41425733 | Unmet information needs and knowledge gaps in cancer patients undergoing oral anticancer therapy. | Explor Res Clin Soc Pharm | 2025 | https://conductscience.org/library/papers/41425733 | PubMed |
| 41325647 | The impact of vertical integration on health care delivery and costs: Evidence from physician-pharmacy integration. | J Health Econ | 2025 | https://conductscience.org/library/papers/41325647 | PubMed |
| 41185868 | Recent advancement in polymeric nanoparticles for oral chemotherapy: Transforming cancer treatment. | Bioimpacts | 2025 | https://conductscience.org/library/papers/41185868 | PubMed |
| 40626013 | Wernicke's encephalopathy following radical gastrectomy and prolonged parenteral nutrition: a case report of pyloric obstruction and undisclosed psychiatric comorbidity. | Front Oncol | 2025 | https://conductscience.org/library/papers/40626013 | PubMed |
| 40525538 | Perceptions of oncology healthcare professional providing care to older adults prescribed oral anticancer medications in the United States: A qualitative study. | J Oncol Pharm Pract | 2025 | https://conductscience.org/library/papers/40525538 | PubMed |
| 40130809 | Trends in the Dispensing of Oral Anti-Cancer Medications Across Australia Over 10 Years. | Pharmacoepidemiol Drug Saf | 2025 | https://conductscience.org/library/papers/40130809 | PubMed |
| 39091323 | Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms. | Ther Adv Hematol | 2024 | https://conductscience.org/library/papers/39091323 | PubMed |
| 37081567 | Outcomes of patient education in adult oncologic patients receiving oral anticancer agents: a systematic review protocol. | Syst Rev | 2023 | https://conductscience.org/library/papers/37081567 | PubMed |
| 36612264 | Novel Strategies for the Bioavailability Augmentation and Efficacy Improvement of Natural Products in Oral Cancer. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36612264 | PubMed |
| 34677244 | Frontline Treatment of the Young, Fit Patient with CLL: A Canadian Perspective. | Curr Oncol | 2021 | https://conductscience.org/library/papers/34677244 | PubMed |
| 33768501 | Patients' Perceived Continuity of Care and Adherence to Oral Anticancer Therapy: a Prospective Cohort Mediation Study. | J Gen Intern Med | 2021 | https://conductscience.org/library/papers/33768501 | PubMed |
| 33409726 | Effectiveness of a nurse-led telephone follow-up in the therapeutic management of patients receiving oral antineoplastic agents: a randomized, multicenter controlled trial (ETICCO study). | Support Care Cancer | 2021 | https://conductscience.org/library/papers/33409726 | PubMed |
| 32588349 | Oral and Subcutaneous Anticancer Therapy Training Course for Non-physician Healthcare Professionals: a Survey Evaluating the Relevance of its Content and its Implications in the Practice of Cancer Care. | J Cancer Educ | 2022 | https://conductscience.org/library/papers/32588349 | PubMed |
| 31848704 | From theory to practice: implementing a standardized, interactive education session on oral anticancer medication (OAM) for patients and their caregivers. | Support Care Cancer | 2020 | https://conductscience.org/library/papers/31848704 | PubMed |
| 31758323 | Improvement in adherence to Capecitabine and Lapatinib by way of a therapeutic education program. | Support Care Cancer | 2020 | https://conductscience.org/library/papers/31758323 | PubMed |
| 31164024 | Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs. | Leuk Lymphoma | 2019 | https://conductscience.org/library/papers/31164024 | PubMed |
| 30625194 | Comparison between continuous and discrete doses for model based designs in cancer dose finding. | PLoS One | 2019 | https://conductscience.org/library/papers/30625194 | PubMed |
| 30463094 | Self-Care Support for Patients with Gastrointestinal Cancer: iCancerHealth. | Appl Clin Inform | 2018 | https://conductscience.org/library/papers/30463094 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EGFR | 1956 | PubTator's text mining | https://conductscience.org/library/genes/1956 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20437116
GET https://conductscience.org/api/papers/v1/20437116/references?page=2